October 16, 2020 – Intalere (St. Louis, MO) announced a new agreement with Immucor, Inc. for blood bank products.
Through this agreement, Intalere members will receive negotiated pricing on Immucor’s blood bank instruments, including Echo Lumena and NEO Iris, which the company says provide fast turnaround times, true continuous access and features the broadest test menu available using Immucor’s exclusive Capture technology for serology-based antibody screening and identification.
Additionally, members have access to Immucor’s complete line of serology-based reagents and PreciseType HEA test, a multiplexed molecular assay that generates detailed molecular information from patient and donor samples, rapidly detecting genotypes for accurate prediction of phenotypes.
The contract is currently effective through September 30, 2023.